Table 2. Univariate and multivariate analysis of predictors of EGFR mutation.
Characteristic | WT | EGFR m+ | Univariate analysis | Multivariate analysis | |||
---|---|---|---|---|---|---|---|
(n = 317) | Odds ratio (95% CI) | p-value | Odds ratio (95% CI) | p-value | |||
Age (years) | |||||||
≤ 65 | 143 | 137 | 1 | ||||
> 65 | 174 | 197 | 1.182 (0.866–1.613) | 0.292 | |||
Sex | |||||||
Female | 136 | 210 | 1 | ||||
Male | 181 | 124 | 0.444 (0.323–0.607) | < 0.001 | |||
Smoking | |||||||
≤ 5 PY | 131 | 229 | 1 | 1 | |||
> 5 PY | 186 | 105 | 0.323 (0.234–0.444) | < 0.001 | 0.357 (0.256–0.494) | < 0.001 | |
Serum CEA level | |||||||
Normal | 157 | 197 | 1 | ||||
Elevated | 160 | 137 | 0.682 (0.500–0.930) | 0.016 | |||
Tumor size | |||||||
< 30 mm | 218 | 243 | 1 | ||||
≥ 30 mm | 99 | 91 | 0.825 (0.587–1.156) | 0.264 | |||
Pathological nodal status | |||||||
N0 | 232 | 277 | 1 | ||||
N1 / N2 | 85 | 57 | 0.562 (0.383–0.818) | 0.003 | |||
Lymphatic permeation | |||||||
Negative | 221 | 253 | 1 | ||||
Positive | 96 | 81 | 0.737 (0.521–1.041) | 0.084 | |||
Vascular invasion | |||||||
Negative | 204 | 251 | 1 | ||||
Positive | 113 | 83 | 0.597 (0.425–0.836) | 0.003 | |||
SUVmax | |||||||
≤ 2.69 | 124 | 200 | 1 | 1 | |||
> 2.69 | 193 | 134 |
WT = wild-type; m+ = mutation-positive; PY = pack years.